World's first biobank for recurrent head and neck cancer launches
NCT ID NCT05885490
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study creates a tissue bank and data registry for people with recurrent head and neck cancer. Researchers will collect samples and health information from thousands of participants to better understand the disease and find better treatments. The goal is to improve survival and set international standards for care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD CANCER NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.